In 2023, mortality from malignant neoplasms of the colon, rectum, and anus among females in Brazil stood at 11.6 thousand deaths. From 2024 to 2028, the forecast suggests a steady annual increase, with year-on-year growth rates of approximately 2.8% from 2024 to 2025, 2.6% from 2025 to 2026, and 2.5% from 2026 to 2027, culminating in a total of 13.22 thousand deaths in 2028. The compound annual growth rate (CAGR) for this period is approximately 2.6%.
Future trends to watch for include advancements in medical treatments, lifestyle changes, and prevention programs. Additionally, any developments in healthcare policy or socioeconomic factors could significantly impact mortality rates moving forward. Continual demographic studies and investment in healthcare infrastructure will be crucial in understanding these mortality trends in Brazil.
